Drug Profile
VF 001
Alternative Names: VF001; VF001-DP HD; VF001-DP LDLatest Information Update: 02 Mar 2022
Price :
$50
*
At a glance
- Originator Factor Therapeutics
- Class Eye disorder therapies; Growth factors; Proteins; Skin disorder therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Diabetic foot ulcer; Eye disorders; Leg ulcer
Most Recent Events
- 23 Feb 2022 No development reported - Phase-II for Leg ulcer in USA (Intradermal)
- 23 Feb 2022 No development reported - Preclinical for Diabetic foot ulcer in Australia (Intradermal)
- 23 Feb 2021 No development reported - Preclinical for Eye disorders in Australia (unspecified route)